These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9240350)

  • 1. A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists.
    Moloney GP; Robertson AD; Martin GR; MacLennan S; Mathews N; Dodsworth S; Sang PY; Knight C; Glen R
    J Med Chem; 1997 Jul; 40(15):2347-62. PubMed ID: 9240350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
    J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.
    Xu YC; Schaus JM; Walker C; Krushinski J; Adham N; Zgombick JM; Liang SX; Kohlman DT; Audia JE
    J Med Chem; 1999 Feb; 42(3):526-31. PubMed ID: 9986723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
    Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
    J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
    Law H; Dukat M; Teitler M; Lee DK; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon RA
    J Med Chem; 1998 Jun; 41(13):2243-51. PubMed ID: 9632357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Goadsby PJ; Hoskin KL
    Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
    Cole DC; Lennox WJ; Stock JR; Ellingboe JW; Mazandarani H; Smith DL; Zhang G; Tawa GJ; Schechter LE
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4780-5. PubMed ID: 16125933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
    Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW
    Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.
    Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R
    Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM; Blaney FE; Davies S; Duckworth DM; Ham P; Jenkins S; Jennings AJ; Joiner GF; King FD; Mulholland KR; Wyman PA; Hagan JJ; Hatcher J; Jones BJ; Middlemiss DN; Price GW; Riley G; Roberts C; Routledge C; Selkirk J; Slade PD
    J Med Chem; 1998 Apr; 41(8):1218-35. PubMed ID: 9548813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
    Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopropyl-tryptamine analogues: synthesis and biological evaluation as 5-HT(6) receptor ligands.
    Szalata C; Szymoniak J; Fabis F; Butt-Gueulle S; Rault S; Bertus P; Gérard S; Sapi J
    ChemMedChem; 2013 Jan; 8(1):70-3. PubMed ID: 23129513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
    Paluchowska MH; Bugno R; Charakchieva-Minol S; Bojarski AJ; Wesołowska A
    Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.